February 3, 2021
A look at potential changes facing FDA-regulated life sciences industry in 2021. Presented by James Boiani of Epstein Becker and Green.
Previously Recorded on December 16, 2020
In this year’s annual year-end wrap-up, a panel that includes members of Medmarc’s Claims team along with David Waxman of Saul Ewing Arnstein & Lehr LLP will summarize the state of the medical device industry for “2020: A Year Unlike Any Other.” The panel will include discussions on areas involving...
Previously Recorded on December 2, 2020
In this installment of Medmarc’s webinar series, Kate Klaus, an attorney and FDA specialist in our Risk Management department, will guide a discussion of the top life sciences news stories of the past year and their potential implications for products liability. Topics will include: The dramatic im...
March 23, 2021
Ireland’s medical technology sector has evolved into one of the leading European clusters for medical technology and diagnostic opportunities. Now in its 8th year Innovation Summit Dublin 2021, located in the heart of this technology sector, is recognized as the leading medical technology investment...